232 related articles for article (PubMed ID: 34429222)
1. Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain.
Ryan P; Valencia J; Cuevas G; Torres-Macho J; Troya J; Pueyo Á; José Muñoz-Gómez M; Muñoz-Rivas N; Vázquez-Morón S; Martinez I; Lazarus JV; Resino S
Int J Drug Policy; 2021 Oct; 96():103424. PubMed ID: 34429222
[TBL] [Abstract][Full Text] [Related]
2. Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care.
Valencia J; Lazarus JV; Ceballos FC; Troya J; Cuevas G; Resino S; Torres-Macho J; Ryan P
Liver Int; 2022 Feb; 42(2):309-319. PubMed ID: 34767680
[TBL] [Abstract][Full Text] [Related]
3. HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study.
Ryan P; Valencia J; Cuevas G; Troya J; Ramon C; Rodríguez A; Torres-Macho J; Muñoz-Gómez MJ; Canorea I; Vázquez-Morón S; Resino S
Int J Drug Policy; 2021 Jun; 92():103134. PubMed ID: 33517130
[TBL] [Abstract][Full Text] [Related]
4. HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study.
Ryan P; Valencia J; Cuevas G; Troya J; Torres-Macho J; Muñoz-Gómez MJ; Muñoz-Rivas N; Canorea I; Vázquez-Morón S; Resino S
Infect Dis Poverty; 2021 Aug; 10(1):111. PubMed ID: 34412695
[TBL] [Abstract][Full Text] [Related]
5. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.
Grebely J; Gilliver R; McNaughton T; Conway A; Cunningham E; Henderson C; Hadlow B; Molloy K; Doab A; Tillakeratne S; Pepolim L; Harrod ME; Dore GJ; Read P
Int J Drug Policy; 2023 Apr; 114():103982. PubMed ID: 36863287
[TBL] [Abstract][Full Text] [Related]
6. Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark.
Demant J; Krohn-Dehli L; Van der Veen J; Øvrehus A; Lazarus JV; Weis N
Int J Drug Policy; 2023 Nov; 121():104185. PubMed ID: 37774576
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility.
MacIsaac MB; Whitton B; Anderson J; Cogger S; Vella-Horne D; Penn M; Weeks A; Elmore K; Pemberton D; Winter RJ; Papaluca T; Howell J; Hellard M; Stoové M; Wilson D; Pedrana A; Doyle JS; Clark N; Holmes JA; Thompson AJ
Int J Drug Policy; 2024 Mar; 125():104317. PubMed ID: 38281385
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C screening and linkage to care with a mobile clinic in Southern Denmark.
Dröse S; Øvrehus ALH; Holm DK; Røge BT; Christensen PB
Int J Drug Policy; 2023 Nov; 121():104180. PubMed ID: 37714009
[TBL] [Abstract][Full Text] [Related]
10. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain.
Saludes V; Antuori A; Lazarus JV; Folch C; González-Gómez S; González N; Ibáñez N; Colom J; Matas L; Casabona J; Martró E
Int J Drug Policy; 2020 Jun; 80():102734. PubMed ID: 32470849
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
[TBL] [Abstract][Full Text] [Related]
13. Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs.
Midgard H; Bjørnestad R; Egeland M; Dahl E; Finbråten AK; Kielland KB; Blindheim M; Dalgard O
Liver Int; 2022 Jun; 42(6):1268-1277. PubMed ID: 35362660
[TBL] [Abstract][Full Text] [Related]
14. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
Blackburn NA; Patel RC; Zibbell JE
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
[TBL] [Abstract][Full Text] [Related]
15. The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T'N'T HepC).
Lazarus JV; Øvrehus A; Demant J; Krohn-Dehli L; Weis N
BMJ Open; 2020 Nov; 10(11):e039724. PubMed ID: 33168560
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
[TBL] [Abstract][Full Text] [Related]
17. Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada.
Broad J; Mason K; Guyton M; Lettner B; Matelski J; Powis J
Int J Drug Policy; 2020 Jun; 80():102755. PubMed ID: 32416538
[TBL] [Abstract][Full Text] [Related]
18. Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care.
Lazarus JV; Herranz A; Picchio CA; Villota-Rivas M; Rodríguez A; Alonso JM; Moratinos A; Perrotta A; Tegeo E; Bibiloni F; Buti M; Vilella À
BMJ Open; 2021 Oct; 11(10):e053394. PubMed ID: 34675021
[TBL] [Abstract][Full Text] [Related]
19. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study.
Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Sharafi H; Shafiei M; Zarei J; Mousavian G; Tavakoli F; Ghalekhani N; Shokoohi M; Khezri M; Mehmandoost S; Shojaei MR; Karamouzian M; Briceno A; Morris MD; Alavian SM; Haghdoost AA; Sharifi H; Page KA
Int J Drug Policy; 2022 Apr; 102():103580. PubMed ID: 35074607
[TBL] [Abstract][Full Text] [Related]
20. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
